search
Back to results

A Study to Assess the Anti-Emetic Efficacy of Ginger in Children and Adolescents Receiving Chemotherapy

Primary Purpose

Nausea, Vomiting

Status
Unknown status
Phase
Phase 3
Locations
India
Study Type
Interventional
Intervention
Provision of capsules containing ginger powder or placebo
Sponsored by
All India Institute of Medical Sciences, New Delhi
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional health services research trial for Nausea focused on measuring Nausea, Vomiting, Chemotherapy

Eligibility Criteria

8 Years - 21 Years (Child, Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • All patients must have a histologically confirmed diagnosis of Osteosarcoma/ Malignant Fibrohistiocytoma of bone that is currently being treated with chemotherapy with high emetogenic potential chemotherapeutic agent(Cisplatin at a dose 120mg/m2 ; Adriamycin 75 mg/m2)
  • Age group : 8-21 yrs.
  • Weight : greater than or equal to 20 kg and less than 40 kg in Category 1
  • Weight : greater than or equal to 40 kg and less than 60 kg in Category 2
  • Patients who are willing to participate in study.
  • Patients or their parents who can understand Hindi or English.

Exclusion Criteria:

  • Patients of age <8 yrs or age >21 yrs.
  • Weight < 20 kg and greater than or equal to 40 kg in Category 1
  • Weight < 40 kg and greater than or equal to 60 kg in Category 2
  • Patients receiving chemotherapy with drugs other than Cisplatin.
  • Patients receiving a dosage of chemotherapy with Cisplatin<120 mg/m2.

Sites / Locations

  • Dr. B.R. Ambedkar Institute Rotary Cancer HospitalRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Ginger arm

Placebo arm

Arm Description

The patients in this arm will be randomly selected in each cycle of chemotherapy. The unit of randomization is the cycle of chemotherapy. In each cycle of chemotherapy of all patients recruited in the study will be categorized using the computer generated random numbers. The patients in the ginger arm; Group A will be getting ginger powder capsules according to their body weight;ie;there are two weight categories within Group A: Category 1- 20kg-40kg Category 2- 40kg-60kg Category 1 will receive 2 capsules 3 times a day,ie; 1gram ginger powder per day Category 2 will receive 5 capsule divided in 3 doses per day,ie; 2gram ginger powder per day

Patients (children and adolescents) will be included in this arm after randomization of the cycle of chemotherapy of the patient. Starch powder/Glucose powder is used as placebo.The patients in the placebo arm; Group B will be getting ginger powder capsules according to their body weight;ie;there are two weight categories within Group B: Category 1- 20kg-40kg Category 2- 40kg-60kg Category 1 will receive 2 capsules 3 times a day,ie; 1gram placebo powder per day Category 2 will receive 5 capsule divided in 3 doses per day,ie; 2gram placebo powder per day

Outcomes

Primary Outcome Measures

Reduction in the Incidence and Severity of Chemotherapy Induced Nausea and Vomiting

Secondary Outcome Measures

Full Information

First Posted
July 15, 2009
Last Updated
July 24, 2009
Sponsor
All India Institute of Medical Sciences, New Delhi
search

1. Study Identification

Unique Protocol Identification Number
NCT00940368
Brief Title
A Study to Assess the Anti-Emetic Efficacy of Ginger in Children and Adolescents Receiving Chemotherapy
Official Title
A Study to Evaluate the Anti-Emetic Effect of Ginger Powder Vs Placebo as an Add-on Therapy in Children and Adolescents Receiving Chemotherapy : A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
July 2009
Overall Recruitment Status
Unknown status
Study Start Date
June 2009 (undefined)
Primary Completion Date
December 2009 (Anticipated)
Study Completion Date
January 2010 (Anticipated)

3. Sponsor/Collaborators

Name of the Sponsor
All India Institute of Medical Sciences, New Delhi

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Ginger root powder is found to be significantly effective,when given as an add-on therapy in reducing chemotherapy induced nausea and vomiting in children and adolescents receiving chemotherapy. It is very cost effective and as compared to the other add-on therapy drug like aprepitant.
Detailed Description
Cisplatin is a chemotherapeutic agent with high emetogenic potential. High doses of Cisplatin (120 mg/m2) induces nausea and vomiting in 90 % of patients. More than 60% of patients experience nausea and vomiting even if they are getting the conventional anti emetic medications. Children and adolescents with cancer are using complementary and alternative medicine (CAM) to relieve symptoms, reduce side effects of treatment, and cope with the emotional aspects of having a life-threatening illness. Parental decisions about using CAM should be based on studies of efficacy and safety . Ginger is already used in traditional folk medicine to treat nausea and vomiting.Additionally, ginger's ability to block 5-HT3 receptors and its free-radical scavenging action in the gut suggests that it may be beneficial for reducing both the prevalence and severity of chemotherapy induced nausea and vomiting. Ginger is an easily available and cost effective substance in Indian scenario; (1gm costs less than one rupees). A dose of 1-2 gm of ginger is found to have favourable effects in reducing the incidence of nausea and vomiting. There are not much side-effects of ginger have been established so far, except mild stomach upset, increased burping and nausea seen in very few patients after the ingestion of ginger. Ginger is a widely available,affordable and acceptable natural substance which is to be included as an additional treatment option for chemotherapy induced nausea and vomiting which will significantly improve the health, compliance with treatment and quality of life of patients receiving chemotherapy.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nausea, Vomiting
Keywords
Nausea, Vomiting, Chemotherapy

7. Study Design

Primary Purpose
Health Services Research
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Ginger arm
Arm Type
Experimental
Arm Description
The patients in this arm will be randomly selected in each cycle of chemotherapy. The unit of randomization is the cycle of chemotherapy. In each cycle of chemotherapy of all patients recruited in the study will be categorized using the computer generated random numbers. The patients in the ginger arm; Group A will be getting ginger powder capsules according to their body weight;ie;there are two weight categories within Group A: Category 1- 20kg-40kg Category 2- 40kg-60kg Category 1 will receive 2 capsules 3 times a day,ie; 1gram ginger powder per day Category 2 will receive 5 capsule divided in 3 doses per day,ie; 2gram ginger powder per day
Arm Title
Placebo arm
Arm Type
Placebo Comparator
Arm Description
Patients (children and adolescents) will be included in this arm after randomization of the cycle of chemotherapy of the patient. Starch powder/Glucose powder is used as placebo.The patients in the placebo arm; Group B will be getting ginger powder capsules according to their body weight;ie;there are two weight categories within Group B: Category 1- 20kg-40kg Category 2- 40kg-60kg Category 1 will receive 2 capsules 3 times a day,ie; 1gram placebo powder per day Category 2 will receive 5 capsule divided in 3 doses per day,ie; 2gram placebo powder per day
Intervention Type
Dietary Supplement
Intervention Name(s)
Provision of capsules containing ginger powder or placebo
Other Intervention Name(s)
Tulsi Ayurvedic Products & Research(P)LTd,U.P.,India
Intervention Description
The patients(children and adolescents) will be provided with Capsules containing either ginger powder or placebo on the three days when they receive chemotherapy. For weight category 1(20-40kg),6 capsules are given in three divided doses and the amount of ginger powder administered per day is 1 gram. For weight category 2(40-60kg), 5 capsules are given in three divided doses and the amount of ginger powder administered per day is 2 gram.
Primary Outcome Measure Information:
Title
Reduction in the Incidence and Severity of Chemotherapy Induced Nausea and Vomiting
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
21 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: All patients must have a histologically confirmed diagnosis of Osteosarcoma/ Malignant Fibrohistiocytoma of bone that is currently being treated with chemotherapy with high emetogenic potential chemotherapeutic agent(Cisplatin at a dose 120mg/m2 ; Adriamycin 75 mg/m2) Age group : 8-21 yrs. Weight : greater than or equal to 20 kg and less than 40 kg in Category 1 Weight : greater than or equal to 40 kg and less than 60 kg in Category 2 Patients who are willing to participate in study. Patients or their parents who can understand Hindi or English. Exclusion Criteria: Patients of age <8 yrs or age >21 yrs. Weight < 20 kg and greater than or equal to 40 kg in Category 1 Weight < 40 kg and greater than or equal to 60 kg in Category 2 Patients receiving chemotherapy with drugs other than Cisplatin. Patients receiving a dosage of chemotherapy with Cisplatin<120 mg/m2.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Anu K, BScNursing
Phone
9109891661848
Email
anukaiims@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Kamlesh K Sharma, MScNursing
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Anu K, BSc.Nursing
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kamlesh K Sharma, MSc.Nursing
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Study Director
First Name & Middle Initial & Last Name & Degree
Sameer Bakhshi, MD
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Study Chair
First Name & Middle Initial & Last Name & Degree
Y K Gupta, MD,FAMS,FIPS
Organizational Affiliation
All India Institute of Medical Sciences, New Delhi
Official's Role
Study Chair
Facility Information:
Facility Name
Dr. B.R. Ambedkar Institute Rotary Cancer Hospital
City
New Delhi
State/Province
Delhi
ZIP/Postal Code
110049
Country
India
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Anu K, BSc. Nursing
Phone
9109891661848
Email
anukaiims@gmail.com
First Name & Middle Initial & Last Name & Degree
Kamlesh K Sharma, MSc. Nursing
Phone
91098911336985
Email
kamlesh_con@yahoo.co.in
First Name & Middle Initial & Last Name & Degree
Anu K, BSc. Nursing

12. IPD Sharing Statement

Citations:
PubMed Identifier
20842754
Citation
Pillai AK, Sharma KK, Gupta YK, Bakhshi S. Anti-emetic effect of ginger powder versus placebo as an add-on therapy in children and young adults receiving high emetogenic chemotherapy. Pediatr Blood Cancer. 2011 Feb;56(2):234-8. doi: 10.1002/pbc.22778. Epub 2010 Sep 14.
Results Reference
derived

Learn more about this trial

A Study to Assess the Anti-Emetic Efficacy of Ginger in Children and Adolescents Receiving Chemotherapy

We'll reach out to this number within 24 hrs